ARCHIVES

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

This article is from The Cancer Letter archive.

Vol. 35 No. 13 | April 3, 2009

Download PDF Visit The Full Archive

Related Articles

ASCO Entering Prime Of Life

May 31, 1991

Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research

June 27, 1997

New Cancer Awards Worth $1 Million a Year Announced

September 30, 1988

NCI Cooperative Group, Cancer Center Trials Listed

February 29, 2008

NCI Conducting Four Epidemiology Studies On Radon

July 1, 1988

News Analysis: Filing Will Ignite Complex Litigation Costing Millions, With Uncertain Rewards

March 9, 2012